Advertisement
Genetic variants may help identify which patients could benefit which patients from more aggressive glycemia treatment
Enhanced protocols and more research warranted
First study of paraoxonase-1 activity levels in psoriatic diseases
Significant bleeding risk may outweigh any benefit
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Higher rates of psychiatric and chronic illnesses seen
Advertisement
Advertisement